Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy pens are prefilled injection devices that contain semaglutide, a GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight and weight-related conditions. Each pen arrives with ultra-fine needles integrated into the delivery system, eliminating the need to purchase needles separately. However, access challenges and pricing concerns have led many patients to explore compounded alternatives that deliver the same active ingredient through licensed 503A compounding pharmacies.
How Wegovy Pens Are Designed and Packaged
Wegovy pens are single-use or multi-dose injection pens that contain premeasured amounts of semaglutide dissolved in a sterile solution. The needle technology built into each pen is specifically engineered for subcutaneous injection, meaning you inject the medication into the fatty tissue just beneath your skin rather than into muscle or vein. The needle gauge and length are calibrated to deliver semaglutide safely and reduce injection-related discomfort, and they are included with every pen shipment at no additional cost.
Each Wegovy pen box typically contains either one or four pens depending on your dosing schedule, along with alcohol swabs for skin preparation. The pens are designed for once-weekly injection, and the needle is automatically retracted after each use to prevent accidental needlesticks. Patients do not need to purchase supplemental needles because the delivery system is fully integrated, making the user experience straightforward for those new to injectable medications.
Storage requirements for Wegovy pens are strict: they must be refrigerated between 36°F and 46°F before first use, and certain pen types can be stored at room temperature for up to 30 days after initial use. The needle remains sealed and protected inside the pen housing until the moment of injection, reducing contamination risk and ensuring sterility throughout the product lifecycle.
Why Patients Are Switching to Compounded Semaglutide Injections
Wegovy shortages have been recurring since its launch in 2021, with supply interruptions lasting months at a time and creating frustration for patients who depend on consistent dosing schedules. Compounded semaglutide from licensed 503A pharmacies offers a reliable alternative that bypasses many of the supply chain bottlenecks affecting brand-name medications. PlexusDx compounded semaglutide injections start at $149 per month and deliver the identical active pharmaceutical ingredient without flat per-compound pricing increases, so your dose may need to go up but your price won't.
Cost predictability is another major factor driving the shift away from Wegovy. Insurance coverage for Wegovy is inconsistent and often requires prior authorization or proof of medical necessity, leaving many patients with out-of-pocket costs exceeding $300 per month. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization, and treatments are HSA and FSA eligible, making compounded semaglutide financially accessible to a broader patient population.
Compounded semaglutide needles are included in every shipment, just as with Wegovy, so patients receive a complete injection kit ready to use immediately upon delivery. The needles supplied with compounded semaglutide are pharmaceutical-grade and designed for safe subcutaneous administration, meeting the same sterility and safety standards as brand-name products.
Understanding GLP-1 Receptor Activation and Individual Response
Semaglutide works by binding to GLP-1 receptors throughout your body, triggering signals in your brain that reduce hunger and increase feelings of fullness while also slowing stomach emptying. The genetic variation in your GLP1R gene (such as rs6923761) influences how efficiently your body's receptors respond to semaglutide, which means two patients receiving identical doses may experience different appetite suppression and weight loss trajectories. PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 pathways and 150+ insights, allowing your provider to personalize your semaglutide dosing strategy based on your unique biology rather than relying on a standard dosing protocol.
Other genetic markers like FTO rs9939609 and MC4R rs17782313 also shape your baseline appetite regulation and metabolic rate, providing additional context for how you may respond to semaglutide therapy. Patients with certain genetic profiles may achieve optimal results at lower doses, reducing side effect burden and monthly treatment cost, while others may require higher doses to reach therapeutic benefit. Precision genetic testing removes guesswork from weight loss medicine and ensures every patient receives treatment aligned with their individual peptide pathways.
Needle Safety and Injection Technique for Semaglutide
Subcutaneous injection using semaglutide needles is straightforward and low-risk when proper technique is followed: clean the injection site with an alcohol swab, pinch the skin to create a small fold, insert the needle at a 45 to 90-degree angle, inject slowly, and withdraw the needle after holding it in place for 3 to 5 seconds. Rotating injection sites between your abdomen, thigh, and upper arm reduces the risk of lipohypertrophy (localized fat thickening) and ensures consistent medication absorption across injections. The needles included with compounded semaglutide are ultra-fine gauge (typically 31G or 32G), meaning they are thinner and shorter than many other injectable medications, minimizing pain and bruising at the injection site.
Common injection-related side effects are rare but include minor bleeding, bruising, or redness around the injection site that typically resolves within 24 hours without intervention. If you experience severe pain, signs of infection such as warmth or pus, or signs of allergic reaction such as difficulty breathing or severe rash, contact your healthcare provider or seek emergency care immediately. PlexusDx provides detailed injection training videos and patient support to ensure safe and confident self-administration from your first dose onward.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do Wegovy pens come with needles included?
Yes, Wegovy pens arrive pre-loaded with integrated ultra-fine needles, so no separate needle purchase is required. Compounded semaglutide from PlexusDx likewise includes pharmaceutical-grade needles with every shipment, ensuring you have everything needed to inject immediately upon delivery.
What is the difference between Wegovy and compounded semaglutide injections?
Wegovy is an FDA-approved brand-name product, while PlexusDx compounded semaglutide contains the identical active ingredient but is manufactured by licensed 503A compounding pharmacies. The clinical effect is the same, but compounded semaglutide offers greater availability, transparent flat pricing starting at $149/month, and no insurance requirement.
How much does semaglutide injection cost at PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month across all commitment tiers, with your dose able to increase without any price change. Treatment is available without insurance, membership fees, or prior authorization, and is eligible for HSA and FSA accounts.
Are compounded semaglutide needles safe?
Yes, needles included with PlexusDx compounded semaglutide meet pharmaceutical-grade sterility and safety standards identical to brand-name products. Proper injection technique, site rotation, and use of alcohol swabs before injection minimize infection risk and ensure safe, comfortable self-administration.
How does the Precision Peptide Genetic Test improve my semaglutide results?
PlexusDx Precision Peptide Genetic Test identifies your genetic variants in GLP1R, GIPR, FTO, MC4R, and 46 other peptide pathways to predict your individual semaglutide response. This personalized data allows your provider to optimize your starting dose and titration schedule, maximizing weight loss while minimizing side effects—available as a $99 add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Zepbound Journey: Can I Take Zepbound at Night for Optimal Well-being?
Navigating Age and Weight Loss: How Old Do You Need to Be to Take Ozempic®?